These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24939645)

  • 1. Conducting an antidepressant clinical trial in oncology: challenges and strategies to address them.
    Park EM; Raddin RS; Nelson KM; Hamer RM; Mayer DK; Bernard SA; Rosenstein DL
    Gen Hosp Psychiatry; 2014; 36(5):474-6. PubMed ID: 24939645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.
    Dowrick CF; Hughes JG; Hiscock JJ; Wigglesworth M; Walley TJ
    BMC Health Serv Res; 2007 Apr; 7():64. PubMed ID: 17470280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocebo effects with antidepressant clinical drug trial placebos.
    Reeves RR; Ladner ME; Hart RH; Burke RS
    Gen Hosp Psychiatry; 2007; 29(3):275-7. PubMed ID: 17484949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive Vitamin D in the treatment of non-remitted depression: Lessons from a failed clinical trial.
    Aucoin M; Cooley K; Anand L; Furtado M; Canzonieri A; Fine A; Fotinos K; Chandrasena R; Klassen LJ; Epstein I; Wood W; Katzman MA
    Complement Ther Med; 2018 Feb; 36():38-45. PubMed ID: 29458928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient trial designs to reduce placebo requirements.
    Krishnan KR
    Biol Psychiatry; 2000 Apr; 47(8):724-6. PubMed ID: 10773179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iprindole, a new antidepressant for use in general office practice. A double blind, placebo-controlled study.
    Hicks JT
    IMJ Ill Med J; 1965 Dec; 128(6):622-6. PubMed ID: 4379035
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo-controlled studies in depression: necessary, ethical and feasible.
    Baldwin D; Broich K; Fritze J; Kasper S; Westenberg H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
    Rihmer Z; Dome P; Baldwin DS; Gonda X
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do antidepressant medications relieve chronic low back pain?
    Turner JA; Denny MC
    J Fam Pract; 1993 Dec; 37(6):545-53. PubMed ID: 8245805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine versus placebo in advanced cancer outpatients.
    Alliot C
    J Clin Oncol; 2004 Jan; 22(1):204-5; author reply 206-8. PubMed ID: 14701790
    [No Abstract]   [Full Text] [Related]  

  • 19. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some of the problems and difficulties associated with clinical studies of antidepressant agents.
    Jenner FA
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):199S-207S. PubMed ID: 334224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.